A vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing and marketing of modernized traditional Chinese medicine.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
A test... for me anyway. Not much experience investing in foreign companies so lets see what happens here. The news sounds promising and that's pretty much all we have to rely on at this point since the company is so young and we don't have many statistics avaiable to give us much of a clue about performance. Anyway, China is huge and getting bigger every day. Middle class is expanding by the minute (just like in India) and they will be using some of their newly acquired dollars to purchase these drugs in order to try and improve the situation for themselves + their families.